Akshay K. Vaishnaw

2021

In 2021, Akshay K. Vaishnaw earned a total compensation of $5.4M as President, Research and Development at Alnylam Pharmaceuticals, a 87% increase compared to previous year.

Compensation breakdown

Non-Equity Incentive Plan$438,150
Option Awards$4,339,785
Salary$632,200
Other$14,900
Total$5,425,035

Vaishnaw received $4.3M in option awards, accounting for 80% of the total pay in 2021.

Vaishnaw also received $438.2K in non-equity incentive plan, $632.2K in salary and $14.9K in other compensation.

Rankings

In 2021, Akshay K. Vaishnaw's compensation ranked 2,366th out of 12,415 executives tracked by ExecPay. In other words, Vaishnaw earned more than 80.9% of executives.

ClassificationRankingPercentile
All
2,366
out of 12,415
81st
Division
Manufacturing
932
out of 5,505
83rd
Major group
Chemicals And Allied Products
355
out of 2,375
85th
Industry group
Drugs
308
out of 2,096
85th
Industry
Pharmaceutical Preparations
200
out of 1,546
87th

Pay ratio

Akshay K. Vaishnaw's Pay$5,425,035
Median Employee's Pay$231,163
Pay Ratio

23

to 1

In 2021, the annual total compensation of Akshay K. Vaishnaw was $5,425,035.

The annual total compensation of the median employee at Alnylam Pharmaceuticals was $231,163.

The ratio of Akshay K. Vaishnaw's pay to the pay of median employee was therefore 23 to one.

Source: SEC filing on April 5, 2022.

Vaishnaw's colleagues

We found four more compensation records of executives who worked with Akshay K. Vaishnaw at Alnylam Pharmaceuticals in 2021.

2021

John Maraganore

Alnylam Pharmaceuticals

Chief Executive Officer

2021

Yvonne Greenstreet

Alnylam Pharmaceuticals

Chief Operating Officer

2021

Tolga Tanguler

Alnylam Pharmaceuticals

Executive Vice President, Chief Commercial Officer

2021

Jeffrey Poulton

Alnylam Pharmaceuticals

Chief Financial Officer

News

In-depth

You may also like